Targeting of keloid with TRAIL and TRAIL-R2/DR5

Volume: 32, Issue: 8, Pages: 957 - 964
Published: Jan 20, 2020
Abstract
Keloid is a common and frequently-occurring disease in plastic surgery, and its ugly appearance and itching symptoms bring mental and life pain to patients. However, the clinical treatment of keloid, such as drug injection treatment, surgical resection, cryotherapy, laser treatment and other therapeutic effects are poor. Since the discovery of tumor necrosis factor related apoptosis inducing ligand (TRAIL) in 1995, its selective apoptosis on...
Paper Details
Title
Targeting of keloid with TRAIL and TRAIL-R2/DR5
Published Date
Jan 20, 2020
Volume
32
Issue
8
Pages
957 - 964
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.